Necitumumab
Portrazza · Anti-EGFR antibody
Severe hypomagnesemia, class effect.
LYTE
ModerateOpen →
Anti-EGFR antibody
Cetuximab & Panitumumab
Erbitux · Vectibix · anti-EGFR
EGFR equals magnesium — block the receptor and the distal tubule wastes it.
MildAnti-EGFR monoclonal antibody · approved 2004
Colorectal (RAS-WT)Head & neck
Signature kidney injury
Electrolyte Wasting
Representative incidence17%
Any-grade hypomagnesemia ~17% overall (RR 5.83); higher with panitumumab. Prolonged therapy >30%.
Source: Tejpar et al., Lancet Oncol 2007; Groenestege et al., JCI 2007
Mechanism of kidney injury
EGFR signaling drives TRPM6-mediated active magnesium reabsorption in the distal convoluted tubule. Blocking EGFR cripples TRPM6 and causes renal magnesium wasting — kidney filtration itself is usually preserved.
Clinical presentation
Hypomagnesemia (fatigue, cramps, tetany, arrhythmia), often with secondary hypocalcemia and hypokalemia.
Onset
Develops over weeks of therapy; worsens with duration.
Reversibility
Reversible
Anticancer mechanism
Monoclonal antibodies that block EGFR to halt proliferation. RAS wild-type colorectal cancer and head & neck cancer.
Management
Oral and IV magnesium repletion (recurrent IV often needed); correct associated hypocalcemia/hypokalemia.
Risk factors
- Longer treatment duration
- Panitumumab > cetuximab
- Older age
- Concurrent diuretics / cisplatin
Prevention
- Baseline and periodic magnesium monitoring
Note · The classic 'EGFR = magnesium' teaching point.
Where it strikes
Nephron segments
Distal Tubule / Collecting Duct
Fine-tuning of Na, K, Mg, acid & water
Injury signatures
Electrolyte Wasting
Beyond the kidney
Class-level context for the major non-renal toxicities of anti-egfr antibodys.
Dermatologic
Rash, HFS, SJS/TEN, vitiligo
- Acneiform rash, paronychia
Gastrointestinal
Diarrhea, colitis, mucositis, perforation
- Diarrhea
Pulmonary
Pneumonitis, ILD, effusions, hypertension
- Interstitial lung disease (EGFR TKIs)
Evidence
5 peer-reviewed references. Citation metadata via PubMed / NLM.
LandmarkImpaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia.Groenestege WM et al. · J Clin Invest 2007 · PMID 17671655Landmark: identifies EGF as a magnesiotropic hormone regulating TRPM6.LandmarkMagnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study.Tejpar S et al. · Lancet Oncol 2007 · PMID 1746689597% develop falling serum magnesium; proves a renal reabsorption defect.PMIDRenal magnification by EGF.Ellison DH et al. · Nephrol Dial Transplant 2008 · PMID 18299299Explains EGFR signaling and TRPM6 in the distal tubule.PMIDMagnesium Absorption in Intestinal Cells: Evidence of Cross-Talk between EGF and TRPM6 and Novel Implications for Cetuximab Therapy.Pietropaolo G et al. · Nutrients 2020 · PMID 33114586Cetuximab down-regulates TRPM6; Mg supplementation does not impair efficacy.PMIDA comparison of panitumumab and cetuximab in the treatment of KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.Liu T et al. · Immunopharmacol Immunotoxicol 2022 · PMID 35950851Comparative hypomagnesemia incidence for the two antibodies.